Prevalence and unadjusted prevalence ratios for delay in the initiation of colorectal cancer treatment among diagnosed but untreated individuals, according to individual characteristics and contextual
BackgroundHigh body mass index (BMI) is a well-established risk factor for ovarian and uterine cancer. However, the global, regional, and national burden of these cancers attributable to high BMI rema
